Biology Reference
In-Depth Information
Cambodia
Denis et al. (2006)
##
28
49
2 (4.1)
15 (30.6)
11.8%
Denis et al. (2006)
##
28
77
1 (1.3)
12 (15.6)
7.7%
Indian Subcontinent
Bangladesh
Thriemer et al. (2010)
42
73
4 (5.5)
6 (8.2)
40%
van den Broek et al. (2005)
42
119
25 (21.0)
20 (16.8)
55.6%
Haque et al. (2007)
42
67
7 (10.4)
10 (14.9)
41.2%
Nepal
Thapa et al. (2007)
†
9
¶
(13.6)
28
64
0 (0.0)
100.0%
Africa
Ethiopia
Assefa et al. (2010)
28
85
5 (5.9)
3 (3.5)
62.5%
Hwang et al. (2011)
42
112
8 (7.1)
1 (0.9)
88.8%
Abbreviations: AM + LUM; artemether + lumefantrine, PCR; polymerase chain reaction.
*When patients were excluded due to recurrent
P. vivax
infection or
P. falciparum
reinfection during the follow-up period, these numbers were added to the eligible
participants.
#
Evaluated three regimens of artemether + lumefantrine at two locations with variable follow-up.
##
Contained details of two separate studies.
§
Before delivery or day 42 if later.
‖
Variable follow-up periods used for different participants.
¶
P. vivax
infection detected by PCR.
†
Includes five patients with mixed infection by PCR at enrolment.
